Ingemar Sjödin

Linköping University — Sweden

Medicine · Health Sciences

16h-index1.4kcitations44works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal motility and disorders(7), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(6), Bipolar Disorder and Treatment(6), Psychosomatic Disorders and Their Treatments(5), Schizophrenia research and treatment(4)

Publications44 total

A possible association between panic disorder and a polymorphism in the preproghrelingene
Psychiatry Research·2012· 23 citedOpen Access
P.1.a.003 A possible association between panic disorder and the ghrelin gene
European Neuropsychopharmacology·2011
A possible association between panic disorder and the ghrelin gene in EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol 21, issue , pp S238-S238
2011
High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
Journal of Clinical Psychopharmacology·2010· 54 cited
Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene
Psychiatric Genetics·2010· 42 cited
P.3.c.020 Olanzapine in serum and cerebrospinal fluid in patients with schizophrenia or schizoaffective disorder
European Neuropsychopharmacology·2010
Association between the catechol-O-methyltransferase Val158Met polymorphism and panic disorder: A replication
Psychiatry Research·2010· 16 cited
Increased CSF Homocysteine in Pathological Gamblers Compared with Healthy Controls
International Journal of Mental Health and Addiction·2008· 1 cited
P.6.e.004 CSF amino acids in pathological gamblers and healthy controls
European Neuropsychopharmacology·2007
Cerebrospinal Fluid Amino Acids in Pathological Gamblers and Healthy Controls
Neuropsychobiology·2007· 68 cited
Absence of the Arg441His polymorphism in the tryptophan hydroxylase 2 gene in adults with anxiety disorders and depression
American Journal of Medical Genetics Part B Neuropsychiatric Genetics·2006· 11 cited
Erratum to “CSF monoamine patterns in pathological gamblers and healthy controls” [J. Psychiatr. Res. 40 (2006) 454–459]
Journal of Psychiatric Research·2006· 5 cited
Mirtazapine naturalistic depression study (in Sweden)—MINDS(S): clinical efficacy and safety
Human Psychopharmacology Clinical and Experimental·2006· 9 cited
P.1.g.001 Increased CSF cholecystokinin, NPY and GABA levels in pathological gambling
European Neuropsychopharmacology·2006
Altered CSF taurine function in pathological gambling
Journal of Psychiatric Research·2005· 9 cited
CSF monoamine patterns in pathological gamblers and healthy controls
Journal of Psychiatric Research·2005· 29 cited
Reduced free tri-iodothyronine serum levels are lower in pathological male gamblers than in healthy male controls
Journal of Psychiatric Research·2004· 1 cited
[Confusion in somatic hospital departments].
PubMed·2004
Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double‐blind, placebo‐controlled, parallel‐group comparison with paroxetine
Human Psychopharmacology Clinical and Experimental·2004· 110 cited
P.3.029 Efficacy of sertraline in improving quality of life and functioning in generalized anxiety disorder (GAD)
European Neuropsychopharmacology·2003· 1 cited
page 1 of 3Next →

Frequent Co-authors

Jan Svedlund(9), Christer Allgulander(7), Kristina Annerbrink(6), Sven Andersch(6), G. Dotevall(5), Conny Nordin(4), Marie Olsson(4), Elias Eriksson(4), Jan‐Otto Ottosson(3), Hans Bendz(3), Lars Westberg(3), Caroline Hansson(3), Suzanne L. Dickson(3), Ulla Lepola(2), Mattias Aurell(2), Elisabeth Skogh(2), Marja­‐Liisa Dahl(2), Göran Holm(2), C. Nordin(2), Torbjörn Ohrt(2)